|
|
||||||||
Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan
To investigate the possible involvement of histamine
H3 receptors in renal noradrenergic neurotransmission,
effects of (R)alpha-methylhistamine (R-HA), a selective
H3-receptor agonist, and thioperamide (Thiop), a selective
H3-receptor antagonist, on renal nerve stimulation (RNS)-induced changes in renal function and norepinephrine (NE) overflow in anesthetized dogs were examined. RNS (0.5-2.0 Hz) produced significant decreases in urine flow and urinary sodium excretion and increases in NE overflow rate (NEOR), without affecting renal hemodynamics. When R-HA (1 µg · kg
1 · min
1) was
infused intravenously, mean arterial pressure and heart rate were
significantly decreased, and there was a tendency to reduce basal
values of urine flow and urinary sodium excretion. During R-HA
infusion, RNS-induced antidiuretic action and increases in NEOR were
markedly attenuated. Thiop infusion (5 µg · kg
1 · min
1) did not
affect basal hemodynamic and excretory parameters. Thiop infusion
caused RNS-induced antidiuretic action and increases in NEOR similar to
the basal condition. When R-HA was administered concomitantly
with Thiop infusion, R-HA failed to attenuate the RNS-induced
antidiuretic action and increases in NEOR. However, in the presence of
pyrilamine (a selective H1-receptor antagonist) or
cimetidine (a selective H2-receptor antagonist) infusion,
R-HA attenuated the RNS-induced actions, similarly to the case without these antagonists. Thus functional histamine H3 receptors,
possibly located on renal noradrenergic nerve endings, may play the
role of inhibitory modulators of renal noradrenergic neurotransmission.
renal nerve stimulation; norepinephrine overflow
This article has been cited by other articles:
![]() |
V. Simonneaux and C. Ribelayga Generation of the Melatonin Endocrine Message in Mammals: A Review of the Complex Regulation of Melatonin Synthesis by Norepinephrine, Peptides, and Other Pineal Transmitters Pharmacol. Rev., June 1, 2003; 55(2): 325 - 395. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |